NICE guidance on type 2 diabetes in adults – what's new?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NICE guidance on type 2 diabetes in adults – what's new?

Published:2016-02-15 Issue:3 Volume:2016 Page:17-22
ISSN:1747-9800
Container-title:Independent Nurse
language:en
Short-container-title:Independent Nurse

Author:

Morris David¹

Affiliation:

1. GP, Shrewsbury

Publisher

Mark Allen Group

Subject

General Medicine

Link

http://www.magonlinelibrary.com/doi/pdf/10.12968/indn.2016.3.17

Reference11 articles.

1. The new NICE guidelines for type 2 diabetes – a critical analysis

2. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

3. The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes

4. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

5. The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of continuous glucose tracking data in people with type 1 diabetes after COVID‐19 vaccination reveals unexpected link between immune and metabolic response, augmented by adjunctive oral medication;International Journal of Clinical Practice;2021-10-07

2. Feasibility study of real-time online text-based CBT to support self-management for people with type 1 diabetes: the Diabetes On-line Therapy (DOT) Study;BMJ Open Diabetes Research & Care;2021-01

3. Evidence-Based Clinical Review on Cardiovascular Benefits of SGLT2 (Sodium-Glucose Co-Transporter Type 2) Inhibitors in Type 2 Diabetes Mellitus;Cureus;2020-08-11

4. Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future;Hospital Practice;2020-03-14

5. A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?;Pharmacological Research;2017-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3